CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-31 | Simpson Curran Chief Executive Officer | Grant or award | +951 | $7.00 | $7K | 343,418 |
| 2025-10-09 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −20,811 | $12.62 | $263K | 216,162 |
| 2025-09-29 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −7,624 | $10.03 | $76K | 236,973 |
| 2025-09-10 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −7,734 | $10.02 | $77K | 244,597 |
| 2025-09-01 | Malzahn Craig Chief Technology Officer | Shares withheld for taxes | −234 | $8.93 | $2K | 17,585 |
| 2025-09-01 | Chan Mitchell Chief Financial Officer | Shares withheld for taxes | −4,901 | $8.93 | $44K | 53,968 |
| 2025-08-01 | Christmas Patrick J. Chief Strategy & Legal Officer | Shares withheld for taxes | −4,699 | $8.19 | $38K | 151,411 |
| 2025-07-01 | Simpson Curran Chief Executive Officer | Shares withheld for taxes | −4,701 | $8.23 | $39K | 252,331 |
| 2025-05-30 | Fox Allan M. Director | Grant or award | +7,768 | 19,054 | ||
| 2025-05-30 | Fox Allan M. Director | Grant or award · Stock Options (Right to Buy) | +39,815 | 39,815 | ||
| 2025-05-30 | Zachary Jennifer Director | Grant or award | +7,768 | 22,064 | ||
| 2025-05-30 | Zachary Jennifer Director | Grant or award · Stock Options (Right to Buy) | +39,815 | 39,815 | ||
| 2025-05-30 | Tasse Daniel Director | Grant or award | +7,768 | 19,054 | ||
| 2025-05-30 | Tasse Daniel Director | Grant or award · Stock Options (Right to Buy) | +39,815 | 39,815 | ||
| 2025-05-30 | STUMP DAVID C Director | Grant or award | +7,768 | 19,054 | ||
| 2025-05-30 | STUMP DAVID C Director | Grant or award · Stock Options (Right to Buy) | +39,815 | 39,815 | ||
| 2025-05-30 | Mills Kenneth T. Director | Grant or award | +7,768 | 482,871 | ||
| 2025-05-30 | Mills Kenneth T. Director | Grant or award · Stock Options (Right to Buy) | +39,815 | 39,815 | ||
| 2025-05-30 | MIGAUSKY GEORGE V Director | Grant or award | +7,768 | 19,054 | ||
| 2025-05-30 | MIGAUSKY GEORGE V Director | Grant or award · Stock Options (Right to Buy) | +39,815 | 39,815 |
Page 4 of 11 · 216 trades